2024 annual financial data
Redhill Biopharma 2024 Operating margin
Redhill Biopharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was -181.69%.
Operating income was -14,613,000 USD and net income was -8,268,000 USD.
Operating cash flow was -9,369,000 USD.
Get free Redhill Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,043,000 USD
- Operating income
- -14,613,000 USD
- Net income
- -8,268,000 USD
- Operating cash flow
- -9,369,000 USD